Hester Bios

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE782E01017
  • NSEID: HESTERBIO
  • BSEID: 524669
INR
1,370.00
17.45 (1.29%)
BSENSE

Mar 25

BSE+NSE Vol: 8.07 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 324228,
    "name": "Hester Bios",
    "stock_name": "Hester Bios",
    "full_name": "Hester Biosciences Ltd",
    "name_url": "stocks-analysis/hester-bios",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,370.00",
    "chg": 17.45,
    "chgp": "1.29%",
    "dir": 1,
    "prev_price": "1,352.55",
    "mcapval": "1,184.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524669,
    "symbol": "HESTERBIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE782E01017",
    "curr_date": "Mar 25",
    "curr_time": "",
    "bse_nse_vol": "8.07 k",
    "exc_status": "Active",
    "traded_date": "Mar 25, 2026",
    "traded_date_str": "2026 03 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/hester-bios-324228-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Hester Biosciences Ltd Technical Momentum Shifts Amid Bearish Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-technical-momentum-shifts-amid-bearish-signals-3906202",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/HesterBioscienc_technicaldot_3906202.png",
        "date": "2026-03-23 08:00:34",
        "description": "Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from mildly bearish to a more pronounced bearish trend. Despite some mildly bullish weekly indicators, the overall technical landscape remains cautious, with key metrics such as MACD, RSI, and moving averages signalling a challenging near-term outlook for the stock."
      },
      {
        "title": "Hester Biosciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hester-biosciences-ltd-is-rated-sell-3902904",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/HesterBioscienc_mojoScore_3902904.png",
        "date": "2026-03-20 10:10:03",
        "description": "Hester Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 20 March 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Hester Biosciences Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-3902209",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/HesterBioscienc_technicaldot_3902209.png",
        "date": "2026-03-20 08:00:47",
        "description": "Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish trend. Despite a modest day gain of 1.64%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators, reflecting cautious investor sentiment amid broader market challenges."
      },
      {
        "title": "Hester Biosciences Ltd Faces Bearish Momentum Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-faces-bearish-momentum-amid-mixed-technical-signals-3899579",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/HesterBioscienc_technicaldot_3899579.png",
        "date": "2026-03-19 08:00:46",
        "description": "Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. Despite some mildly bullish weekly indicators, the overall technical landscape remains cautious, reflecting the stock’s recent underperformance relative to the broader market benchmarks."
      },
      {
        "title": "Hester Biosciences Ltd Sees Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-sees-technical-momentum-shift-amid-mixed-market-signals-3895587",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/HesterBioscienc_technicaldot_3895587.png",
        "date": "2026-03-17 08:01:08",
        "description": "Hester Biosciences Ltd has exhibited a subtle shift in price momentum, transitioning from a bearish to a mildly bearish technical trend. Despite a 3.48% gain on 17 Mar 2026, the stock’s technical indicators present a complex picture, with some oscillators signalling cautious optimism while others remain subdued. This nuanced movement warrants a detailed analysis for investors seeking clarity on the stock’s near-term trajectory."
      },
      {
        "title": "Hester Biosciences Declines 5.03%: Mixed Technical Signals and Valuation Shifts Shape the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-declines-503-mixed-technical-signals-and-valuation-shifts-shape-the-week-3891360",
        "imagepath": "",
        "date": "2026-03-14 15:06:28",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>9 Mar:</strong> Technical momentum shifts amid mixed market signals and valuation reclassification</p>\n                    <p><strong>10 Mar:</strong> Technical momentum turns more bearish with increased downside pressure</p>\n                    <p><strong>13 Mar:</strong> Week closes with a 5.03% decline, underperforming the Sensex</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,484.75</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,410.00</div><div class=\"stat-change negative..."
      },
      {
        "title": "Hester Biosciences Ltd Technical Momentum Shifts Amid Bearish Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-technical-momentum-shifts-amid-bearish-signals-3881806",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/HesterBioscienc_technicaldot_3881806.png",
        "date": "2026-03-10 08:01:12",
        "description": "Hester Biosciences Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a modest recovery in the past year, the stock’s recent price action and technical parameters suggest caution for investors amid weakening momentum and persistent downward pressures."
      },
      {
        "title": "Hester Biosciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hester-biosciences-ltd-is-rated-sell-3879155",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/HesterBioscienc_mojoScore_3879155.png",
        "date": "2026-03-09 10:10:02",
        "description": "Hester Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Hester Biosciences Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-3878761",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/HesterBioscienc_technicaldot_3878761.png",
        "date": "2026-03-09 08:00:29",
        "description": "Hester Biosciences Ltd has experienced a nuanced shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish trend. Despite a recent downgrade in its Mojo Grade to 'Sell' from 'Strong Sell', the stock exhibits mixed signals across key technical indicators such as MACD, RSI, and moving averages, reflecting a complex market sentiment in the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 5443,
    "sid": "324228",
    "stock_news_url": "https://www.marketsmojo.com/news/hester-biosciences-324228"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
      "datetime": "20-Mar-2026",
      "details": "Intimation of Credit Ratings",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Diversification / Disinvestment",
      "datetime": "11-Mar-2026",
      "details": "Intimation for Divestment of Equity Stake in Texas Lifesciences Private Limited Subsidiary of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
      "datetime": "11-Mar-2026",
      "details": "Outcome of Board Meeting and Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Divestment of Equity stake in Texas Lifesciences Private Limited Subsidiary",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has declared <strong>70%</strong> dividend, ex-date: 06 Aug 25",
          "dt": "2025-08-06",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 27 Sep 12",
          "dt": "2012-09-27",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has announced <strong>2:5</strong> rights issue, ex-date: 29 May 06",
          "dt": "2006-05-29",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views

Hester Biosciences Declines 5.03%: Mixed Technical Signals and Valuation Shifts Shape the Week

2026-03-14 15:06:28

Key Events This Week

9 Mar: Technical momentum shifts amid mixed market signals and valuation reclassification

10 Mar: Technical momentum turns more bearish with increased downside pressure

13 Mar: Week closes with a 5.03% decline, underperforming the Sensex

stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Credit Rating

20-Mar-2026 | Source : BSE

Intimation of Credit Ratings

Announcement under Regulation 30 (LODR)-Diversification / Disinvestment

11-Mar-2026 | Source : BSE

Intimation for Divestment of Equity Stake in Texas Lifesciences Private Limited Subsidiary of the Company.

Board Meeting Outcome for Outcome Of Board Meeting

11-Mar-2026 | Source : BSE

Outcome of Board Meeting and Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Divestment of Equity stake in Texas Lifesciences Private Limited Subsidiary

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Hester Biosciences Ltd has declared 70% dividend, ex-date: 06 Aug 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Hester Biosciences Ltd has announced 1:2 bonus issue, ex-date: 27 Sep 12

stock-summary
RIGHTS

Hester Biosciences Ltd has announced 2:5 rights issue, ex-date: 29 May 06